Search Results

Researchers achieve breakthrough in treating vision loss with iPSC-derived corneal epithelial cell sheets. (Representational Image-Wikimedia Commons)
Ankur Deka
4 min read
A first-in-human trial reveals the potential of iPSC-derived corneal epithelial cell sheets for treating limbal stem cell deficiency
Rebecsinib, reverses malignant hyper-editing by an inflammation-induced protein isoform, known as ADAR1 p150.
MBT Desk
3 min read
In cancer stem cell and animal models, rebecsinib reversed overactive protein splicing of ADAR1 protein that drives cloning capacity and immune evasion by many malignancies.
A mother and daughter bonding while using tablet a warm joyful interaction.
MBT Desk
8 min read
Separating Hope from Hype: What the Evidence Says About MAHA's Autism Treatments
someone putting blood in test tubes through a syringe.
MBT Desk
2 min read
The Centre has amended the Drugs Rules, 1945 to bring stem cell therapies, gene therapeutics and xenografts under stricter licensing and regulatory oversight.
A woman checking her glucose levels with a glucometer.
Dr. Theresa Lily Thomas
3 min read
A novel stem cell therapy in China reportedly reversed type 2 diabetes in a patient.
A child's hands play with colorful wooden animal toys on a light table.
MBT Desk
3 min read
Moreover, the Court also noted that an unproven therapy cannot be “demanded by a patient as a matter of right”.
Read More
logo
Medbound Times
www.medboundtimes.com